COVID-19
South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients
May 6, 2020Research and Development COVID-19, coronavirus, south korea
South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
Pharmafile.com’s weekly COVID-19 news round-up
May 6, 2020Research and Development COVID-19, coronavirus
Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …
Ousted chief of BARDA says Trump administration ignored COVID-19 warnings
May 6, 2020Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine
Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …
First French case of COVID-19 occurred in December, a month earlier than previously thought
May 5, 2020Manufacturing and Production COVID-19, coronavirus
A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
UK contact-tracing app being tested on the Isle of Wight
May 5, 2020Manufacturing and Production COVID-19, coronavirus
The NHS’s coronavirus contract tracing app has been published to Apple and Google’s app stores with council staff and healthcare …
Lonza and Moderna enter agreement to mass produce coronavirus vaccine
May 4, 2020Sales and Marketing COVID-19, coronavirus
Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …
FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir
Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …
Trump vows to reduce America’s reliance on foreign drug imports
May 4, 2020Sales and Marketing COVID-19, coronavirus
President Donald Trump has vowed to cut the US’s reliance on foreign drugs, singling out China and Ireland as countries …
UK testing experimental treatment for use in COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, coronavirus, coronavirus treatment
British scientists are testing an experimental drug to help some of society’s most vulnerable fight off the COVID-19 coronavirus.
Mike Pompeo says there is evidence COVID-19 was made in a lab, despite US intelligence saying it occurred naturally
May 4, 2020Sales and Marketing COVID-19, Wuhan Institute of virology, coronavirus, lab, pandemic
US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …
NHS sets out plans to deal with the second phase of the pandemic
May 1, 2020Medical Communications COVID-19, coronavirus
The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …
COVID-19 pandemic likely to last two years, study says
May 1, 2020Medical Communications COVID-19, coronavirus, pandemic
The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …
Top Ten most popular articles on Pharmafile.com this week
May 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs
The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine
April 30, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma
A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
